Subbiah V - Search Results

1

IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, Buford AS, Fokt I, Skora S, Wang J, Naing A, Lazar AJ, Rohren EM, Daw NC, Subbiah V, Benjamin RS, Ratan R, Priebe W, Mikos AG, Amin HM, Ludwig JA. Lamhamedi-Cherradi SE, et al. Among authors: subbiah v. J Natl Cancer Inst. 2016 Aug 30;108(12):djw182. doi: 10.1093/jnci/djw182. Print 2016 Dec. J Natl Cancer Inst. 2016. PMID: 27576731 Free PMC article.

2

Ewing's sarcoma: standard and experimental treatment options.

Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Subbiah V, et al. Curr Treat Options Oncol. 2009 Apr;10(1-2):126-40. doi: 10.1007/s11864-009-0104-6. Epub 2009 Jun 17. Curr Treat Options Oncol. 2009. PMID: 19533369 Review.

3

Of mice and men: divergent risks of teriparatide-induced osteosarcoma.

Subbiah V, Madsen VS, Raymond AK, Benjamin RS, Ludwig JA. Subbiah V, et al. Osteoporos Int. 2010 Jun;21(6):1041-5. doi: 10.1007/s00198-009-1004-0. Epub 2009 Jul 14. Osteoporos Int. 2010. PMID: 19597911

4

Neoadjuvant treatment of soft-tissue sarcoma: a multimodality approach.

Reynoso D, Subbiah V, Trent JC, Guadagnolo BA, Lazar AJ, Benjamin R, Pollock RE, Ludwig JA. Reynoso D, et al. Among authors: subbiah v. J Surg Oncol. 2010 Mar 15;101(4):327-33. doi: 10.1002/jso.21481. J Surg Oncol. 2010. PMID: 20187067 Review.

5

Review: Ewing sarcoma treatment: a role for bisphosphonates?

Subbiah V, Ludwig JA. Subbiah V, et al. Clin Adv Hematol Oncol. 2010 Jul;8(7):503-4. Clin Adv Hematol Oncol. 2010. PMID: 20864919 Review. No abstract available.

6

Targeted Therapy of Ewing's Sarcoma.

Subbiah V, Anderson P. Subbiah V, et al. Sarcoma. 2011;2011:686985. doi: 10.1155/2011/686985. Epub 2010 Oct 31. Sarcoma. 2011. PMID: 21052545 Free PMC article.

7

Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.

Subbiah V, Naing A, Brown RE, Chen H, Doyle L, LoRusso P, Benjamin R, Anderson P, Kurzrock R. Subbiah V, et al. PLoS One. 2011 Apr 6;6(4):e18424. doi: 10.1371/journal.pone.0018424. PLoS One. 2011. PMID: 21494688 Free PMC article.

8

Ewing's sarcoma: overcoming the therapeutic plateau.

Subbiah V, Kurzrock R. Subbiah V, et al. Discov Med. 2012 Jun;13(73):405-15. Discov Med. 2012. PMID: 22742646 Free PMC article.

9

Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials.

Subbiah IM, Subbiah V, Tsimberidou AM, Naing A, Kaseb AO, Javle M, Fu S, Hong DS, Piha-Paul S, Wheler JJ, Hess KR, Janku F, Falchook GS, Wolff RA, Kurzrock R. Subbiah IM, et al. Among authors: subbiah v. Oncotarget. 2013 Jan;4(1):156-65. doi: 10.18632/oncotarget.832. Oncotarget. 2013. PMID: 23391555 Free PMC article. Clinical Trial.

10

Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications.

Jiang Y, Janku F, Subbiah V, Angelo LS, Naing A, Anderson PM, Herzog CE, Fu S, Benjamin RS, Kurzrock R. Jiang Y, et al. Among authors: subbiah v. Oncotarget. 2013 Jun;4(6):884-9. doi: 10.18632/oncotarget.1021. Oncotarget. 2013. PMID: 23800680 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters